For citations:

Morinaka A., Tsutsumi Y., Yamada M., Suzuki K., Watanabe T., Abe T., Furuuchi T., Inamura S., Sakamaki Y., Mitsuhashi N., Ida T., Livermore DM. OP0595, A NEW DIAZABICYCLOOCTANE: MODE OF ACTION AS A SERINE β-LACTAMASE INHIBITOR, ANTIBIOTIC AND β-LACTAM 'ENHANCER'. Antibiotiki i Khimioterapiya = Antibiotics and Chemotherapy. 2015;60(11-12):51-52. (In Russ.)